Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
OtherOn TRACK

On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing

Kurt C. Stange
The Annals of Family Medicine March 2007, 5 (2) 175-178; DOI: https://doi.org/10.1370/afm.685
Kurt C. Stange
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Effect of Multiple Factors on Harm or Benefit of Direct-to-Consumer (DTC) Ads

    FactorEffect on Ratio of DTC Harm to Benefit
    Condition severity
        Serious↑ potential benefit
        Mild↑ risk of harm
    Prevalence of condition
        Rare↑ risk of harm
        Common↓ risk of harm
    Effectiveness of treatment
        High↑ potential for benefit
        Low↓ potential for benefit
    Side effects of treatment
        Severe and/or common↑ risk of harm
        Mild and/or rare↓ risk of harm
    Rate of treatment
        Undertreated↑ potential for benefit
        Not undertreated↑ risk of harm
    • View popup
    Table 2.

    Effects of Direct-to-Consumer Ads in the Most Favorable and Unfavorable Combinations of Drug and Medical Conditions

    Condition
    Drug TypeSevere, Prevalent, or Undertreated ConditionMild, Rare, or Overtreated Condition
    Effective drug with rare or mild side effectsLikely beneficialIncreased medicalization and cost for a small benefit and rare hazard
    Low-effectiveness drug with severe or common side effectsBeneficial for a small subgroup
 Hazardous for most viewersPublic health hazard
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 5 (2)
The Annals of Family Medicine: 5 (2)
Vol. 5, Issue 2
1 Mar 2007
  • Table of Contents
  • Index by author
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing
Kurt C. Stange
The Annals of Family Medicine Mar 2007, 5 (2) 175-178; DOI: 10.1370/afm.685

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing
Kurt C. Stange
The Annals of Family Medicine Mar 2007, 5 (2) 175-178; DOI: 10.1370/afm.685
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • DTC PHARMACEUTICAL MARKETING
    • OTHER NOTEWORTHY THREADS OF DISCUSSION
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Time to Ban Direct-to-Consumer Prescription Drug Marketing
  • Google Scholar

More in this TOC Section

  • Modifying the Measurement Paradigm or Questioning its Very Assumptions
  • On-the-Ground Wisdom About Care Integration
  • The Conversation Continues, as It Should
Show more On TRACK

Similar Articles

Subjects

  • Other research types:
    • Health policy
  • Other topics:
    • Ethics

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine